New York Assault Attorney Russ Kofman Sheds Light on Self-Defense Laws in New Article

Lebedin Kofman LLP presents an insightful overview of self-defense laws in New York with the help of New York assault attorney Russ Kofman (https://www.lebedinkofman.com/understanding-self-defense-laws-in-new-york-assault-cases/). With a comprehensive understanding of the intricacies involved in these legal matters, Russ Kofman emphasizes the critical nature of informed legal guidance for individuals facing assault charges.

The legal defense of self-defense in New York assault cases requires more than just a claim of feeling threatened. It demands a demonstration that the perceived danger was reasonable and that the response was proportionate to that threat. As the article from Lebedin Kofman LLP elaborates, the state’s laws outline specific criteria for the justified use of force, underscoring the importance of having knowledgeable legal support to navigate these nuances. Russ Kofman, a dedicated New York assault attorney, can analyze the circumstances of each case to determine the viability of a self-defense claim.

In New York, self-defense is defined as the use of reasonable force to protect oneself from imminent physical harm. The force used must be proportional to the threat faced, a principle deeply embedded in state statutes. This distinction between justifiable defensive actions and excessive use of force is crucial in avoiding criminal charges. Russ Kofman, a prominent New York assault attorney, emphasizes the importance of this legal framework in providing clear guidelines for both citizens and the courts.

Self-defense in New York is recognized as an affirmative defense in criminal law, meaning that if an individual is charged with a crime like assault, they can justify their actions through self-defense if specific criteria are met. According to Russ Kofman, the defendant must initially present evidence supporting their claim. If the defense is established, the prosecution must then prove beyond a reasonable doubt that the defendant’s actions were not justified. Successfully proving self-defense can lead to acquittal or reduced charges, highlighting the necessity of skilled legal representation from a knowledgeable New York assault attorney such as Russ Kofman.

Several key principles govern self-defense laws in New York. These include the reasonable belief of threat, proportionality of force, and the duty to retreat. Russ Kofman, a New York assault attorney, explains that an individual must have a reasonable belief of imminent danger of being harmed unlawfully. The force used in self-defense must match the level of threat. Additionally, New York law mandates a duty to retreat, where possible, to avoid using deadly force, except when an individual is in their own home, as per the Castle Doctrine.

Proving a self-defense claim in court involves presenting clear evidence that the defendant acted reasonably under an imminent threat. According to Russ Kofman, this includes physical evidence, medical records, and any weapons involved. Witnesses and surveillance footage also play a vital role in corroborating the defendant’s account. Successfully proving self-defense can result in acquittal or lesser charges, significantly impacting the outcome of the case. Russ Kofman’s extensive experience as a New York assault attorney can be instrumental in effectively presenting these elements in court.

A common misconception about self-defense laws in New York is the belief that any physical response is justified if one feels threatened. However, as Russ Kofman clarifies, the law requires that the threat must be immediate and the response proportional. Media portrayals often skew public perception, leading to misunderstandings about the ease of validating a self-defense claim. The reality is that these claims are rigorously scrutinized, requiring a thorough and informed legal strategy.

Immediate legal counsel is crucial for anyone facing assault charges. Russ Kofman, a distinguished New York assault attorney, emphasizes the importance of timely legal advice to understand one’s rights and the legal intricacies of self-defense. From preserving evidence to navigating police interrogations, Russ Kofman can provide invaluable guidance. Early legal representation can significantly impact the course of legal proceedings, helping ensure that the defendant’s actions are appropriately defended.

About Lebedin Kofman LLP:

Lebedin Kofman LLP is a leading law firm in New York, well-versed in criminal defense, particularly assault cases. The firm is dedicated to providing exceptional legal representation and protecting clients’ rights. With a focus on personalized service and a deep understanding of New York’s legal landscape, Lebedin Kofman LLP can offer support for those facing legal challenges.

Embeds:

YouTube Video: https://www.youtube.com/watch?v=8djQzmtm_qQ

GMB: https://www.google.com/maps?cid=8774315708012683965

Email and website

Email: info@lebedinkofman.com

Website: https://www.lebedinkofman.com/

Media Contact
Company Name: Lebedin Kofman LLP
Contact Person: Russ Kofman
Email: Send Email
Phone: (646) 663-4430
Address:26 Broadway 3rd floor
City: New York
State: New York 10004
Country: United States
Website: https://www.lebedinkofman.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New York Assault Attorney Russ Kofman Sheds Light on Self-Defense Laws in New Article

Metastatic Castration-Resistant Prostate Cancer Pipeline Drugs 2024

DelveInsight’s, “Metastatic Castration-Resistant Prostate Cancer Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Castration-Resistant Prostate Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Key Takeaways from the Metastatic Castration-Resistant Prostate Cancer Pipeline Report

  • August 2024:- Janssen Research & Development, LLC- A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Metastatic Prostate Cancer. The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP and placebo.
  • August 2024:- Hansoh BioMedical R&D Company- ARTEMIS-003: A Phase 2, Open-label, Multi-center Study to Evaluate Efficacy, Safety, and Pharmacokinetics, of Intravenous Administration of HS-20093 in Patients With Metastasis Castration Resistant Prostate Cancer and Advanced Solid Tumors Who Have Progressed Following at Least One Prior Therapy
  • DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic Castration-Resistant Prostate Cancer treatment.
  • The leading Metastatic Castration-Resistant Prostate Cancer Companies working in the market include Surface Oncology, Regeneron Pharmaceuticals, Clovis Oncology, AstraZeneca, Veru Healthcare, Hinova Pharmaceuticals, Zenith Epigenetic, Eli Lilly and Company, Lantern Pharma, Astellas Pharma/Seagen, Pfizer, Progenics Pharmaceutical, Molecular Insight Pharmaceuticals, Bayer, Accutar Biotechnology Inc, Hinova Pharmaceuticals, Taiho Oncology, Inc., Forma Therapeutics, Inc., Dizal Pharmaceuticals, Amgen, and others.
  • Promising Metastatic Castration-Resistant Prostate Cancer Therapies in the various stages of development include JNJ-78278343, Cetrelimab, Cabazitaxel, TVB-2640, Enzalutamide, Abiraterone acetate, JNJ-56021927, Xofigo (Radium-223 dichloride, BAY88-8223), and others.

 

Request a sample and discover the recent advances in Metastatic Castration-Resistant Prostate Cancer treatment drugs @ Metastatic Castration-Resistant Prostate Cancer Pipeline Outlook Report

 

Metastatic Castration-Resistant Prostate Cancer Overview

Prostate cancer (PCa) is one of the most prevalent malignancies in the world and the third most common cause of male cancer-related death in the United States of America (USA). The majority of men with newly diagnosed PCa present with localized disease and undergo radical prostatectomy and/or radiological therapy, followed by androgen deprivation therapy (ADT). Depending on the grade of the cancer, a variable percentage of these patients experience progression to castration-resistant prostate cancer (CRPC) within 10 years. CRPC was previously named “hormone-refractory prostate cancer” and “androgen-independent prostate cancer”. However, because castration treatments including ADT were ineffective, these cancers still showed reliance upon hormones for androgen receptor (AR) activation.

 

Metastatic Castration-Resistant Prostate Cancer Emerging Drugs Profile

 

  • SRF617: Surface Oncology

SRF617 is a fully human antibody designed to inhibit the enzymatic activity of CD39 in the tumor microenvironment, allowing for a dual mechanism of action to promote anti-tumor immunity via reduction of immunosuppressive adenosine in addition to increasing levels of immunostimulatory ATP. SRF617 has been granted Orphan Drug designation for the treatment of advanced pancreatic cancer by the FDA.

 

  • Rucaparib: Clovis Oncology

Rucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3 being developed in multiple tumor types, including ovarian and metastatic castration-resistant prostate cancers, as monotherapy, and in combination with other anti-cancer agents. Exploratory studies in other tumor types are also underway.

 

  • HP518: Hinova Pharmaceuticals

HP518, a highly selective and orally bioavailable chimeric degrader targeting androgen receptor (AR) with the potential to overcome the drug resistance of prostate cancer due to some specific AR mutations. In discovery and preclinical studies, HP518 showed high degradation activity against wild type AR and some specific AR mutants that are resistant to enzalutamide, and excellent antitumor activity in xenograft mouse models. HP518 is highly selective for AR.

 

Find out more about Metastatic Castration-Resistant Prostate Cancer treatment drugs @ Drugs for Metastatic Castration-Resistant Prostate Cancer Treatment

 

Metastatic Castration-Resistant Prostate Cancer Therapeutics Assessment

There are approx. 75+ key Metastatic Castration-Resistant Prostate Cancer companies which are developing the therapies Metastatic Castration Resistant Prostate cancer. The Metastatic Castration-Resistant Prostate Cancer companies which have their Metastatic Castration Resistant Prostate cancer drug candidates in the most advanced stage, i.e phase III include Clovis Oncology.

 

DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report covers around 75+ products under different phases of clinical development like

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates

 

Learn more about the emerging Metastatic Castration-Resistant Prostate Cancer pipeline therapies @ Metastatic Castration-Resistant Prostate Cancer Clinical Trials

 

Metastatic Castration Resistant Prostate cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

  • Oral
  • Intravenous
  • Subcutaneous

 

Metastatic Castration-Resistant Prostate Cancer Products have been categorized under various Molecule types such as

  • Small molecule
  • Cell Therapy
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Metastatic Castration-Resistant Prostate Cancer Companies

Surface Oncology, Regeneron Pharmaceuticals, Clovis Oncology, AstraZeneca, Veru Healthcare, Hinova Pharmaceuticals, Zenith Epigenetic, Eli Lilly and Company, Lantern Pharma, Astellas Pharma/Seagen, Pfizer, Progenics Pharmaceutical, Molecular Insight Pharmaceuticals, Bayer, Accutar Biotechnology Inc, Hinova Pharmaceuticals, Taiho Oncology, Inc., Forma Therapeutics, Inc., Dizal Pharmaceuticals, Amgen, and others.

 

Dive deep into rich insights for new drugs for Metastatic Castration-Resistant Prostate Cancer Treatment, visit @ Metastatic Castration-Resistant Prostate Cancer Drugs

 

Scope of the Metastatic Castration-Resistant Prostate Cancer Pipeline Report

  • Coverage- Global
  • Metastatic Castration-Resistant Prostate Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Metastatic Castration-Resistant Prostate Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
  • Metastatic Castration-Resistant Prostate Cancer Companies- Surface Oncology, Regeneron Pharmaceuticals, Clovis Oncology, AstraZeneca, Veru Healthcare, Hinova Pharmaceuticals, Zenith Epigenetic, Eli Lilly and Company, Lantern Pharma, Astellas Pharma/Seagen, Pfizer, Progenics Pharmaceutical, Molecular Insight Pharmaceuticals, Bayer, Accutar Biotechnology Inc, Hinova Pharmaceuticals, Taiho Oncology, Inc., Forma Therapeutics, Inc., Dizal Pharmaceuticals, Amgen, and others.
  • Metastatic Castration-Resistant Prostate Cancer Therapies- JNJ-78278343, Cetrelimab, Cabazitaxel, TVB-2640, Enzalutamide, Abiraterone acetate, JNJ-56021927, Xofigo (Radium-223 dichloride, BAY88-8223), and others.

 

For further information on the Metastatic Castration-Resistant Prostate Cancer Pipeline Therapeutics, reach out @ Metastatic Castration-Resistant Prostate Cancer Treatment Drugs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Metastatic Castration Resistant Prostate cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Metastatic Castration Resistant Prostate cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Rucaparib: Clovis Oncology
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Surface Oncology: SRF 617
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I/II)
  14. REGN 4336: Regeneron Pharamceuticals
  15. Drug profiles in the detailed report…..
  16. Early Stage Products (Phase I)
  17. HP 518: Hinova Pharmaceuticals
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Metastatic Castration Resistant Prostate cancer Key Companies
  21. Metastatic Castration Resistant Prostate cancer Key Products
  22. Metastatic Castration Resistant Prostate cancer- Unmet Needs
  23. Metastatic Castration Resistant Prostate cancer- Market Drivers and Barriers
  24. Metastatic Castration Resistant Prostate cancer- Future Perspectives and Conclusion
  25. Metastatic Castration Resistant Prostate cancer Analyst Views
  26. Metastatic Castration Resistant Prostate cancer Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic Castration-Resistant Prostate Cancer Pipeline Drugs 2024

AI Image Generator Market Future Scope, Size, Share, Trends, Growth Factors, Industry Analysis, Advance Technology And Forecast – 2030

“Google (US), Microsoft (US), AWS (US), Adobe (US), Nvidia (US), OpenAI (US), Meta (US), Anthropic (US), Databricks (US), Synthesia (UK), Runway AI (US), Jasper (US), Krea AI (US), Simplified (US), Lumen5 (US), Lightricks (Israel), Hypotenuse AI (US), Writesonic (US), Colossyan (UK).”
AI Image Generator Market by Technology (Convolutional Neural Networks, Autoregressive Models, Diffusion Models; Image Generation, Image Captioning, Image Manipulation, Video Generation, Video Synthesis, Video Editing) – Global Forecast to 2030.

The AI image generator market is expected to grow from USD 8.7 billion in 2024 to USD 60.8 billion in 2030, at a CAGR of 38.2% during the forecast period. AI technologies such as generative AI speed up the creation of content allowing producers and artists to quickly produce visually stunning content that is customized to each viewer’s taste. In addition to its artistic uses it democratizes the creation of professional content introduces cutting-edge styles and techniques and increases productivity by automating tedious tasks. Furthermore, generative AI is redefining the way users produce and engage with image and video content boosting customization increasing accessibility for people with disabilities and enabling training and simulations in a variety of industries.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235119833  

By offering, the services segment to account for higher CAGR during the forecast period

The services segment is anticipated to register the highest CAGR in the Al image generator market driven by several strong factors during the forecast period. Companies across diverse sectors are striving to leverage generative Al technologies as they develop in complexity to enhance their digital media proficiencies. The increasing demand for customized high-quality visual content including videos and images is driving up the need for specialized services that can customize AI-based image generator solutions accordingly. To cut expenses improve marketing and expedite production businesses are beginning to use Al-driven content creation services more frequently.

By image segment, image resolution increase is expected to hold the largest market share during the forecast period

Image based applications are growing in popularity to improve and modify content through different techniques. The AI image generator market is seeing a rise in the use of image resolution increase due to the quick advancements in deep learning techniques and the growing need for top-notch visual content. AI-based image generators offer the best solutions in sectors such as retail and ecommerce, healthcare, and entertainment to improve image quality through automation and create interesting images. This trend is also driven by the demand for a better customer experience and the integration of AI into various processes.

By Vertical, retail & eCommerce are projected to grow at the highest CAGR during the forecast period

The retail & ecommerce sectors are witnessing the highest compound annual growth rate (CAGR) in the Al image generator market owing to their prompt adoption of generative Al for enhancing customer engagement and operational efficiency. Through personalized content and more efficient marketing strategies, retailers and e-commerce platforms are utilizing Al to improve customer experiences. With the aid of generative Al innovations such as virtual changing rooms, customized ads, and tailored product recommendations are making shopping more pleasurable. The ability to quickly producing personalized images and videos increases revenue and customer engagement which drives these industries expansion.

Asia Pacific is expected to grow at the highest CAGR during the forecast period

During the forecast period, the Asia Pacific region is anticipated to grow at the highest compound annual growth rate (CAGR) in the Al image generator market. With nations such as China, South Korea and India at the forefront of Al research and development, Asia is home to some of the most vibrant technological hubs. Rapid developments and applications of generative Al are facilitated by this technological prowess. Various businesses across this region utilize generative AI technology for customized marketing, improved visual content, and streamlined production procedures. Furthermore, Asia’s varied cultural landscape fuels demand for digital content that is localized and customized which in turn propels the development of generative Al technologies that enable the mass production of customized media. In addition, a young tech-savvy populace in the region is more likely to experiment with and adopt new technologies especially those used in the media and creative industries.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=235119833  

Unique Features in the AI Image Generator Market

The degree of customisation offered to consumers is one of the market’s most notable aspects for AI picture generators. Certain programs provide users extensive control over the composition, colors, and style of the output photographs. Users might, for example, choose various art movements (such as impressionism or surrealism) or even imitate particular artists’ methods. For artists and designers trying to make images that fit with their own vision or business identity, this customisation is especially helpful.

The capability to create images straight from text descriptions is another important feature. With this feature, users can enter descriptive words, and the AI will produce an image that corresponds with the description. This is especially helpful when creating content because it allows for immediate concept visualization.

AI image generators are increasingly offering interactive user interfaces, allowing real-time adjustments to the images being created. Features like drag-and-drop, sliders for adjusting attributes (e.g., brightness, contrast, texture), and live previews have made these tools more user-friendly. This interactivity helps users refine their images more efficiently, reducing the need for extensive post-editing.

High-resolution image output is another distinguishing feature in the market. Some AI image generators are capable of producing images at a resolution suitable for professional use, including print media. This feature is crucial for industries such as advertising, fashion, and entertainment, where high-quality visuals are essential.

Many AI image generators are now integrating with other software and platforms, enhancing their usability. For example, integration with graphic design software (like Adobe Photoshop) allows for seamless workflow and further editing capabilities. Similarly, some tools integrate with social media platforms, making it easier to create and share images directly.

Major Highlights of the AI Image Generator Market

Rapid technological breakthroughs have defined the AI image generator business. The quality and realism of generated images have significantly improved as a result of the development of complex algorithms, especially those based on Diffusion Models and Generative Adversarial Networks (GANs).

AI image generators are widely used in a variety of industries, including as gaming, entertainment, advertising, and fashion. Companies are using these technologies to produce aesthetically pleasing material at a larger scale while cutting down on the expenses and time involved in using more conventional design methods.

One of the most significant highlights is the expansion of creative possibilities enabled by AI image generators. These tools allow users to explore new artistic styles, experiment with different visual concepts, and push the boundaries of traditional design.

As the market has grown, there has been an increased focus on making AI image generation accessible to a broader audience. Many platforms offer user-friendly interfaces, making it easy for non-experts to create professional-quality images.

The integration of AI image generators into broader AI-driven workflows is another key highlight. These tools are increasingly being used in combination with other AI technologies, such as natural language processing (NLP) and automated video editing, to create cohesive and immersive content experiences.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235119833  

Top Companies in the AI Image Generator Market

Key players operating in the AI image generator market across the globe are Google (US), Microsoft (US), AWS (US), Adobe (US), Nvidia (US), OpenAI (US), Meta (US), Anthropic (US), Databricks (US), Synthesia (UK), Runway AI (US), Jasper (US), Krea AI (US), Simplified (US), Lumen5 (US), Lightricks (Israel), Hypotenuse AI (US), Writesonic (US), Colossyan (UK), D-ID (Israel), Midjourney (US), Descript (US), Animaker (US), DeepBrain (US), Caspa AI (UK),  Facet AI (US), Fliki (US), Elai (US), Speechify (US), Inworld AI (US), Invideo (US), HeyGen (US), Tavus (US), Lovo AI (US). These companies employ various organic and inorganic approaches, including introducing new products, forming strategic partnerships and collaborations, and engaging in mergers and acquisitions to expand their presence and offerings within the AI image generator market.

Microsoft, a well-known international technology business that was founded in 1975 provides a wide range of products including cloud services software and hardware. With its main office in Redmond, Washington the business has operations in more than 190 nations. Microsoft Office Azure cloud computing platform and Windows operating system are some of its flagship products. Microsoft’s strategic priorities include AI cloud computing and productivity tools. The business caters to both enterprise and consumer markets. In recent years Microsoft has expanded its offering to include more advanced generative AI solutions. With its Azure OpenAI service, the company provides users with access to cutting-edge models for creating images and videos.  Microsoft integrates with systems such as Azure Cognitive Services and makes use of tools like DALL-E which produces high-quality images from written descriptions. Through its integration, new avenues for professional and creative applications are made possible including the creation of synthetic media and video content. These developments demonstrate Microsoft’s dedication to using cutting-edge technology to boost creativity and productivity across a range of industries.

Google, an Alphabet Inc. subsidiary has its headquarters located in Mountain View, California is a major player in the global technology and internet services industry. Google is leading the way in innovation by introducing cutting-edge AI tools, Veo and Imagen 3, for transforming image and video creation. Google’s dedication to improving creative processes through technology is demonstrated by these innovative AI models. Veo is designed to create top-notch videos based on textual prompts, comprehending cinematic ideas and delivering coherent and visually attractive material. This tool aims to greatly assist videographers by simplifying the production process while preserving artistic vision. Also, Imagen 3 delivers realistic images based on written descriptions, providing fine details and limited visual disturbances. This model enhances users’ creativity, making it adaptable to a variety of applications from advertising to personal communication. Together, Veo and Imagen 3 demonstrate Google’s strategy to integrate AI into the creative process and foster collaboration and innovation across the digital media industry.

OpenAI leads the way in innovative artificial intelligence, especially in developing generative models for producing images and videos. Its key products, DALL-E 2 and Sora, showcase this progress. DALL-E 2, introduced in November 2022, transformed the process of generating images by enabling users to produce intricate images based on written descriptions, rapidly establishing itself as a top tool in the industry. Building on this success, OpenAI introduced Sora, a cutting-edge text-to-video generator that transforms text content into visual content. Sora is designed to create high-quality videos that are accurate at every moment, meet user specifications, and demonstrate deep storytelling insights. This model not only enhances the creative potential of content creators, but also simplifies the production process, allowing it to be used for a variety of purposes, from marketing to education. OpenAI’s commitment to advancing ethical AI makes these tools useful in keeping with its broader mission to advance general AI for the benefit of humanity.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ai-image-video-generator-market-235119833.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AI Image Generator Market Future Scope, Size, Share, Trends, Growth Factors, Industry Analysis, Advance Technology And Forecast – 2030

Long Island Estate Planning Attorney Seth Schlessel Releases Article on Upcoming Estate Tax Exemption Sunset in 2026

As the 2026 sunset of the federal estate tax exemption approaches, Long Island estate planning attorney Seth Schlessel (https://www.schlessellaw.com/estate-tax-exemption-sunset-2026/) from Schlessel Law PLLC advises New York residents to reassess their estate planning strategies. The scheduled reduction in the federal estate tax exemption could lead to significant tax liabilities for many estates that were previously exempt under the current laws.

In 2026, the federal estate tax exemption is set to revert to its pre-2018 levels due to the expiration of the Tax Cuts and Jobs Act (TCJA) of 2017. This change will have a profound impact on estate planning, particularly for New York residents who may find themselves newly subject to both federal and state estate taxes. Seth Schlessel, an experienced Long Island estate planning attorney, emphasizes the importance of understanding these impending changes and taking proactive steps to protect one’s estate.

Long Island estate planning attorney Seth Schlessel explains that under the current law, the federal estate tax exemption is approximately $13.61 million per individual. However, when the TCJA provisions sunset in 2026, this exemption will be significantly reduced, potentially exposing many estates to federal estate taxes. “Many individuals who were previously shielded from federal estate taxes will now need to reconsider their estate plans to avoid unexpected tax burdens,” says Schlessel.

The situation is further complicated by New York’s unique estate tax structure, which includes a “cliff” provision. This provision means that if the value of an estate exceeds 105% of the New York estate tax exemption—currently set at $6.94 million—the entire estate becomes subject to state estate tax, not just the amount over the exemption. Seth Schlessel, a Long Island estate planning attorney, highlights the importance of understanding both federal and state tax thresholds to avoid unanticipated tax liabilities. “The interaction between federal and New York state tax laws can lead to significant tax obligations for estates that slightly exceed the exemption limits,” he notes.

With the anticipated reduction in the federal estate tax exemption, more New York estates could become liable for both federal and state estate taxes. This shift underscores the need for careful and strategic estate planning. According to Long Island estate planning attorney Seth Schlessel, New Yorkers should consider revisiting their estate plans and implementing strategies such as lifetime gifting and the use of trusts to minimize tax liabilities. “Adapting estate plans to align with the changing tax landscape is crucial to preserving wealth and ensuring that one’s financial legacy is protected,” advises Schlessel.

To illustrate the potential impact of these changes, Seth Schlessel provides several examples of how New York estates might be affected. For instance, an estate valued at $10 million would be subject to New York state estate tax on the entire amount if it exceeds the state exemption limit, despite being below the current federal exemption. In contrast, an estate valued at $15 million would face taxes at both the state and federal levels, highlighting the need for strategic planning to mitigate tax liabilities.

Proactive financial tactics, such as annual gifting and the use of Irrevocable Life Insurance Trusts (ILITs), are also recommended by Seth Schlessel. These strategies can help reduce the size of a taxable estate and provide tax-free funds for beneficiaries to cover estate taxes and other expenses. “By taking advantage of the current gift tax exclusions and implementing trusts, New Yorkers can effectively minimize their estate’s exposure to future tax liabilities,” advises Schlessel.

The upcoming changes in estate tax laws present significant challenges, but with careful planning and professional guidance, New York residents can take steps to mitigate potential tax burdens and secure their family’s financial future. Long Island estate planning attorney Seth Schlessel is committed to helping clients prepare for the 2026 estate tax exemption sunset and beyond.

About Schlessel Law PLLC:

Schlessel Law PLLC is a Long Island-based law firm well-versed in estate planning, elder law, and probate matters. Led by experienced attorney Seth Schlessel, the firm is dedicated to providing clients with comprehensive legal services tailored to their unique needs. Schlessel Law PLLC takes a proactive approach to estate planning, helping clients navigate complex tax laws and safeguard their financial legacies.

Embeds:

YouTube Video: https://www.youtube.com/watch?v=AZDWLlK7HE8

GMB: https://www.google.com/maps?cid=7387587768064061142

Email and website

Email: seth@schlessellaw.com

Website: https://www.schlessellaw.com/

Media Contact
Company Name: Schlessel Law PLLC
Contact Person: Seth Schlessel
Email: Send Email
Phone: (516) 574-9630
Address:34 Willis Ave Suite 300
City: Mineola
State: New York 11501
Country: United States
Website: https://www.schlessellaw.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Long Island Estate Planning Attorney Seth Schlessel Releases Article on Upcoming Estate Tax Exemption Sunset in 2026

Absolute Awakenings Treatment Center Expands Addiction Treatment Services with Comprehensive Partial Hospitalization Program in New Jersey

“Absolute Awakenings Treatment Center”

Morris Plains, NJ – Absolute Awakenings Treatment Center is proud to announce the expansion of its addiction treatment services with the introduction of a comprehensive Partial Hospitalization Program (PHP). Located in Morris Plains, New Jersey, Absolute Awakenings is committed to providing personalized care to individuals on their journey to recovery, offering a range of programs tailored to meet each client’s unique needs.

Understanding the Partial Hospitalization Program (PHP)

At Absolute Awakenings, we recognize that each person’s path to recovery is unique. Our Partial Hospitalization Program is designed for those who require intensive support but do not need round-the-clock care. This program bridges the gap between inpatient and outpatient care, offering a structured and supportive environment that allows clients to receive treatment during the day while returning to their homes or sober living arrangements in the evening.

Services Offered in the PHP

Our PHP includes a variety of evidence-based therapies and services aimed at addressing the physical, emotional, and psychological aspects of addiction. Clients will have access to individual therapy, group counseling, family therapy, and holistic approaches such as mindfulness and stress management techniques. Additionally, the program offers medical and psychiatric care, ensuring a comprehensive approach to recovery.

A Path to Recovery

The Partial Hospitalization Program at Absolute Awakenings is a critical component of our commitment to helping individuals achieve lasting recovery. By providing a balance of structure and flexibility, the program allows clients to develop the skills and resilience needed to maintain sobriety in the long term. Our experienced team of addiction specialists is dedicated to supporting each client every step of the way, empowering them to reclaim their lives.

About Absolute Awakenings Treatment Center

Absolute Awakenings Treatment Center is a leading provider of addiction treatment services in New Jersey. With a focus on individualized care, the center offers a variety of programs designed to meet the unique needs of each client. From detoxification to long-term recovery support, Absolute Awakenings is committed to helping individuals achieve and maintain sobriety.

Contact Information:

Absolute Awakenings Treatment Center  

3000 NJ-10, Morris Plains, NJ 07950  

Phone: (973) 784-8981  

Email: Admissions@absoluteawakenings.com  

Website: https://absoluteawakenings.com

Media Contact
Company Name: Absolute Awakenings New Jersey Drug & Alcohol Rehab
Contact Person: Admission Office
Email: Send Email
Phone: 9737848981
Address:3000 NJ-10
City: Morris Plains
State: NJ 07950
Country: United States
Website: www.absoluteawakenings.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Absolute Awakenings Treatment Center Expands Addiction Treatment Services with Comprehensive Partial Hospitalization Program in New Jersey

New Jersey Gun Crime Lawyer Adam M. Lustberg Explains the NJ NICS Background Check Process

Adam M. Lustberg (https://www.lustberglaw.com/blog/what-is-nj-nics/), a distinguished New Jersey gun crime lawyer at Lustberg Law Offices, LLC, recently shed light on the intricacies of the New Jersey National Instant Criminal Background Check System (NICS) in a detailed article. The article provides crucial insights into how the NJ NICS process works and its significance in the context of firearm purchases within the state.

Adam M. Lustberg, with his extensive experience as a New Jersey gun crime lawyer, explains that the NJ NICS is a mandatory background check process for anyone looking to purchase a firearm in the state. The system, which is designed to prevent the sale of firearms to individuals who are prohibited by law from owning them, is a critical component of New Jersey’s stringent gun control measures.

As a New Jersey gun crime lawyer, Adam M. Lustberg emphasizes the importance of understanding the NJ NICS process for both firearm sellers and buyers. He notes that while the federal NICS system is well-known, New Jersey’s system operates with additional state-specific regulations that are crucial for residents to be aware of. In his article, Lustberg goes on to explain the step-by-step procedure involved in the NJ NICS process, highlighting the various checks and balances that are in place to ensure public safety.

“The NJ NICS is not just a formality; it’s a critical process that helps maintain the safety of communities,” says Adam M. Lustberg in his article. “Understanding how this system works is essential for anyone involved in the purchase or sale of firearms in New Jersey.”

The article dives deep into the specific requirements that must be met for a successful background check. Adam M. Lustberg details how the NJ NICS process begins with a thorough review of the purchaser’s criminal history, mental health records, and other relevant factors that could disqualify them from owning a firearm. He also touches on the legal implications of the NJ NICS, including what happens when an individual is denied clearance to purchase a firearm.

In the article, Lustberg also discusses the common reasons for delays or denials in the NJ NICS process. As a New Jersey gun crime lawyer, he advises individuals who experience such issues to seek legal counsel to understand their rights and options. According to Lustberg, “Delays in the NJ NICS process can be frustrating, but they are often a result of the thoroughness required to ensure that firearms do not end up in the wrong hands.”

The article also highlights the role of the NJ State Police in administering the NICS checks, working in conjunction with federal authorities to enforce the state’s gun laws. Adam M. Lustberg notes that while the process is designed to be efficient, there are times when it can be prolonged due to the need for additional investigations or clarifications.

For those navigating the complexities of New Jersey’s firearm laws, Adam M. Lustberg’s insights as a New Jersey gun crime lawyer provide valuable guidance. His article emphasizes the importance of compliance with the NJ NICS process and the potential consequences of attempting to circumvent it. Lustberg points out that violations of New Jersey’s firearm laws can result in severe penalties, including criminal charges, fines, and imprisonment.

Adam M. Lustberg provides practical advice for individuals involved in the NJ NICS process. He urges those who are unsure about their eligibility to consult with a qualified New Jersey gun crime lawyer before attempting to purchase a firearm. He also advises firearm dealers to stay informed about the latest legal developments to avoid inadvertently violating the law.

Adam M. Lustberg’s comprehensive overview of the NJ NICS process is a must-read for anyone involved in the purchase or sale of firearms in New Jersey. His article not only clarifies the legal requirements but also underscores the importance of adhering to them to ensure public safety.

About Lustberg Law Offices, LLC:

Lustberg Law Offices, LLC, led by Adam M. Lustberg, is a premier law firm based in Hackensack, NJ. The firm is dedicated to providing high-quality legal representation in a wide range of criminal defense matters, including gun crimes. Adam M. Lustberg, the principal attorney, is known for his commitment to protecting the rights of his clients and ensuring they receive fair treatment under the law. With a focus on thorough preparation and strategic defense, Lustberg Law Offices, LLC has established a strong reputation for achieving positive outcomes in complex legal cases.

Embeds:

YouTube Video: https://www.youtube.com/watch?v=y-aWHeUD6Sk

GMB: https://www.google.com/maps?cid=17248268094099978177

Email and website

Email: alustberg@lustberglaw.com

Website: https://www.lustberglaw.com/

Media Contact
Company Name: Lustberg Law Offices, LLC
Contact Person: Adam M. Lustberg
Email: Send Email
Phone: (201) 880-5311
Address:One University Plaza Dr Suite 210
City: Hackensack
State: New Jersey 07601
Country: United States
Website: https://www.lustberglaw.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Jersey Gun Crime Lawyer Adam M. Lustberg Explains the NJ NICS Background Check Process

True Life Care Mental Health New Jersey Remains Fully Operational and Committed to Serving the Community

“True Life Care Mental Health in New Jersey”

Denville, NJ – August 20, 2024 – True Life Care Mental Health in New Jersey is pleased to announce that our facility is fully operational and continues to provide comprehensive mental health services to the community. Despite recent rumors or misinformation circulating that suggest our center is closed, we assure the public that we are open and fully committed to delivering the highest quality of care.

True Life Care Mental Health is a leading mental health center in New Jersey, dedicated to offering compassionate, patient-centric care. Our team of highly skilled professionals provides a wide range of personalized treatment programs designed to address various mental health disorders. We are committed to helping our patients navigate their unique mental health challenges and improving their overall quality of life.

Our mission is to create a nurturing, supportive, and stigma-free environment where individuals can openly share their experiences and concerns about mental health. We believe in empowering our patients with the tools and support they need to achieve mental wellness.

We invite anyone in New Jersey seeking mental health support to reach out to True Life Care Mental Health. Our doors are open, and we are here to help you on your journey to recovery.

For more information, please contact:

Admission Office

True Life Care Mental Health New Jersey

(973) 490-4563

https://truelifecarementalhealth.com/

About True Life Care Mental Health New Jersey:

True Life Care Mental Health is a comprehensive mental health center located in Denville, New Jersey. We specialize in providing effective and compassionate care to individuals struggling with a wide range of mental health disorders. Our goal is to support our patients in improving their quality of life through personalized treatment programs, all within a caring and stigma-free environment.

Media Contact
Company Name: True Life Care Mental Health New Jersey New Jersey
Contact Person: Admission Office
Email: Send Email
Phone: (973) 490-4563
Address:3000 NJ-10 Suite A
City: Morris Plains
State: NJ, 07950
Country: United States
Website: truelifecarementalhealth.com?utm_source=Google&utm_medium=Local+SEO&utm_campaign=Press+Release&utm_term=Mental+Health+New+Jersey

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: True Life Care Mental Health New Jersey Remains Fully Operational and Committed to Serving the Community

Corporate Wellness Market is expected to reach US$ 117.9 billion by 2031, driven by heightened awareness of employee health, escalating healthcare costs, and the increasing focus on mental health

“Reports and Insights Business Research Pvt. Ltd.”
Corporate Wellness Market was valued at US$ 53.0 billion in 2024 and is expanding at a CAGR of 4.47% from 2024 to 2032

According to the latest report by Reports and Insights, titled, “Corporate Wellness Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast” the global corporate wellness market was valued at USD 53.0 billion in 2024. Looking forward, Reports and Insights anticipates the market to expand at a compound annual growth rate (CAGR) of approximately 4.47% from 2024 to 2032. 

Corporate wellness encompasses a range of strategies and programs implemented by organizations to improve the health and well-being of their employees. These initiatives may include fitness activities, mental health support, nutritional advice, stress management sessions, and preventive health check-ups. The aim is to foster a healthier, more engaged, and productive workforce by addressing employees’ physical, mental, and emotional needs, which in turn can lead to reduced healthcare expenses, lower absenteeism, and higher employee satisfaction and retention.

Get a PDF Sample for more detailed market insights: https://www.reportsandinsights.com/report/corporate-wellness-market

Corporate Wellness Market Trends

The corporate wellness market is rapidly expanding due to heightened awareness of employee health, escalating healthcare costs, and the increasing focus on mental health. Key trends include the adoption of digital health tools, personalized wellness programs, and the use of data analytics to monitor and enhance employee health. Companies are offering comprehensive wellness initiatives that encompass physical, mental, and emotional well-being, with an emphasis on preventive care and chronic disease management. Moreover, there is a growing trend towards fostering a supportive workplace culture that prioritizes work-life balance and stress reduction.

Ask Customization and Browse full report with TOC & List of Figure:  https://www.reportsandinsights.com/report/corporate-wellness-market#

The service segment is estimated to grow at the fastest pace through the forecast period

On the basis of service, the segment is categorized into fitness, health risk assessment, health screening, smoking cessation, stress management and nutrition & weight management. Among these, the fitness sub-segment is currently leading the corporate wellness market. This prominence is driven by an increased focus on physical health, the extensive availability of fitness programs, and the use of technology such as fitness apps and wearable devices. Companies are increasingly recognizing the advantages of promoting physical activity, which improves overall health, enhances productivity, reduces absenteeism, and boosts employee morale. As a result, fitness initiatives, including gym memberships, on-site fitness classes, and virtual workout sessions, have become essential components of corporate wellness programs.

The category segment accounted for the largest share in the corporate wellness market in 2023

On the basis of service, the segment is categorized into psychological therapists, fitness & nutrition consultants and organizations/employers. Among these, the organizations/employers sub-segment is currently leading the corporate wellness market. This trend is driven by companies’ increasing recognition of the advantages of investing in employee health, including boosted productivity, decreased absenteeism, and improved employee satisfaction and retention. Businesses are adopting extensive wellness programs that integrate fitness, nutrition, mental health support, and preventive care. By prioritizing employee wellness, employers are fueling the demand for diverse wellness services and embedding them into their organizational culture.

The end-use segment is estimated to grow with highest CAGR during the forecast period of corporate wellness market

On the basis of end-use, the segment is categorized into large scale organizations, medium scale organizations and small-scale organizations. Among these, large-scale organizations are the leading segment in the corporate wellness market. Their dominance is driven by their capacity to invest heavily in comprehensive wellness programs that include fitness, mental health support, and preventive care. With their extensive resources and infrastructure, these organizations can effectively implement and sustain these initiatives, resulting in increased employee engagement, productivity, and overall well-being. Consequently, large-scale organizations are the key drivers of growth and innovation in corporate wellness, surpassing medium and small-scale organizations.

Request Sample Pages: https://www.reportsandinsights.com/sample-request/2187

Asia Pacific has registered fastest growth rate during the forecast period in corporate wellness market

During the forecast period, the Asia-Pacific region has experienced the fastest growth in the corporate wellness market. This surge is driven by the region’s booming economies, heightened awareness of employee well-being, and the growing implementation of wellness programs by businesses. The emphasis on health and productivity, particularly in rapidly developing countries like China and India, along with an increasing number of large and medium-sized companies, is fueling the demand for corporate wellness solutions in this area.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Wellness Corporate Solutions
  • ComPsych
  • Provant Health Solutions
  • Beacon Health Options
  • Virgin Pulse
  • Marino Wellness
  • EXOS
  • Vitality Group
  • Privia Health
  • Central Corporate Wellness
  • Wellsource, Inc.

The report has segmented the market based on service, category, delivery model, end-use and regions.

Breakup by Service

  • Fitness
  • Health Risk Assessment
  • Health Screening
  • Smoking Cessation
  • Stress Management
  • Nutrition & Weight Management

Breakup by Category

  • Psychological Therapists
  • Fitness & Nutrition Consultants
  • Organizations/Employers

Breakup by Delivery Model

  • Offsite
  • Onsite

Breakup by End-use

  • Large Scale Organizations
  • Medium Scale Organizations
  • Small Scale Organizations

Breakup by Region:

North America

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Benelux
  • Nordic
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • ASEAN
  • Australia & New Zealand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Israel
  • Rest of MEA

 

Browse Other Reports by Reports and Insights:

https://www.reportsandinsights.com/report/menopause-wellness-market

https://www.reportsandinsights.com/report/health-and-wellness-market

About Us:

Rеports and Insights consistеntly mееt intеrnational bеnchmarks in thе markеt rеsеarch industry and maintain a kееn focus on providing only thе highеst quality of rеports and analysis outlooks across markеts, industriеs, domains, sеctors, and vеrticals. Wе havе bееn catеring to varying markеt nееds and do not compromisе on quality and rеsеarch еfforts in our objеctivе to dеlivеr only thе vеry bеst to our cliеnts globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Media Contact
Company Name: Reports and Insights Business Research Pvt Ltd
Contact Person: Ashwani Kailiya
Email: Send Email
Phone: 8307999379
Address:1820, Avenue M
City: Brooklyn
State: NY
Country: United States
Website: https://www.reportsandinsights.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Corporate Wellness Market is expected to reach US$ 117.9 billion by 2031, driven by heightened awareness of employee health, escalating healthcare costs, and the increasing focus on mental health

Colorectal Cancer Pipeline Drugs 2024 | Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences Inc.

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2024” report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our comprehensive Colorectal Cancer Pipeline Report to stay informed about the latest advancements. Download copy now @ Colorectal Cancer Pipeline Outlook

 

Key Takeaways from the Colorectal Cancer Pipeline Report

  • August 2024:- Bristol-Myers Squibb- A Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Metastatic Colorectal Cancers. The purpose of this study is to investigate treatment with nivolumab in combination with trametinib with or without ipilimumab in participants with previously treated cancer of the colon or rectum that has spread.
  • August 2024:- Seagen Inc.- An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
  • DelveInsight’s Colorectal Cancer pipeline report depicts a robust space with 195+ active players working to develop 200+ pipeline therapies for Colorectal Cancer treatment.
  • The leading Colorectal Cancer Companies working in the market include Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences, Inc., Neogap Therapeutics AB, Criterium, Inc., Daiichi Sankyo, Inc., Bristol-Myers Squibb, Celyad Oncology SA, Pfizer, Akeso, Menarini Group, Elpiscience (Suzhou) Biopharma, Ltd., BeyondBio Inc., Shanghai Henlius Biotech, Rottapharm Biotech, Innovative Cellular Therapeutics Inc., BioNTech SE, and others.
  • Promising Colorectal Cancer Therapies in the various stages of development include Patritumab Deruxtecan, Adagrasib, Geptanolimab, PolyPEPI1018, Grapiprant, eFT508, MEN1611, Aldoxorubicin Hydrochloride, Etrumadenant, AL2846, ABI-009, RO7198457, Dabrafenib, AlloStim, TG6002, Onvansertib, BLYG8824A, Napabucasin, GM102, QL1203, CPGJ602, PM060184, Donafenib, IBI310, Spartalizumab, CMAB009, YYB101, ATP128, Vicriviroc, CXD101, Arfolitixorin, SGM-101, RRx-001, APR003, E7386, Trastuzumab, Trilaciclib, MGN1703, BBI608, CYAD-101, SHR-A1811,  EDP1503, SCT-I10A, KL-140, V941, NKTR-255, TEW-7197, MGD019, KPT-8602, GRT-C901, LUM015, IDE196, CAN04, NC410, LOAd703, CEA CAR-T cells, BOLD-100, OBI-833, GRT-C903, IGM-8444, RGX-202-01, NE-201, DS-8201, GCC19CART, M 9140, LYL845, and others.

 

Find out more about Colorectal Cancer treatment drugs @ Drugs for Colorectal Cancer Treatment

 

Colorectal Cancer Emerging Drugs Profile

  • XL092 : Exelixis

XL092 is an investigational small molecule, oral tyrosine kinase inhibitors (TKI) that inhibits the activity of receptor tyrosine kinases involved in cancer growth and spread, including VEGF receptors, MET, AXL and MER. These receptor tyrosine kinases are involved in both normal cellular function and in pathologic processes like oncogenesis, metastasis, and tumor angiogenesis. Currently it is in Phase III stage of clinical trial evaluation to treat Colorectal Cancer.

  • Adagrasb : Mirati Therapeutics

Adagrasib is an investigational, highly selective, and potent oral small-molecule inhibitor of KRASG12C that is optimized to sustain target inhibition, an attribute that could be important to treat KRASG12C-mutated cancers. The drug candidate is being evaluated as monotherapy and in combination with other anti-cancer therapies in patients with advanced KRASG12C-mutated colorectal cancer. Currently being evaluated in the Phase III studies.

  • Olaparib : Merck Sharp & Dohme LLC/Astrazeneca

Olaparib is an investigational is a first-in-class Poly (ADP-ribose) polymerase PARP inhibitors and the first targeted treatment that potentially exploit DNA damage response (DDR) pathway deficiencies, like BRCA mutations, to preferentially kill cancer cells. Olaparib is being jointly developed and commercialized by AstraZeneca and Merck. Currently the drug is being evaluated in Phase III for the treatment of Colorectal Cancer.

  • DS-8201: Daiichi Sankyo

DS-8201 a proprietary antibody-drug conjugate (ADC) is a smart chemotherapy comprised of a humanized HER2 antibody attached to a novel topoisomerase I inhibitor payload by a tetra peptide-based linker. It is designed to target and deliver chemotherapy inside cancer cells and reduce systemic exposure to the cytotoxic payload (or chemotherapy) compared to the way chemotherapy is commonly delivered. The drug is been developed in collaboration with AstraZeneca. The drug is in Phase II stage of clinical trials.

  • Ompenaclid: Inspirna

Ompenaclid is a first in class oral small molecule inhibitor of the creatine transport channel SLC6A8 a novel target that is enriched under hypoxic conditions and provides tumor cells with an additional energy source. Ompenaclid triggers tumor regressions in CRC patients by inducing apoptosis of tumor cells. It is based on Rgenix technology. The drug is in Phase II stage of clinical trials.

  • LYL845: Lyell Immunopharma

LYL845, an autologous tumor-infiltrating lymphocytes (TIL). It is administered through the intravenous route. It is being developed based on an ex vivo epigenetic reprogramming (Epi-R) technology platform is currently being investigated in a Phase 1 clinical trial in patients suffering with relapsed or refractory metastatic colorectal cancer.

  • RG6286: Genentech

RG6286 (BLYG-8824A) is under development for the treatment of relapsed or refractory, advanced, or metastatic colorectal cancer. It is new chemical entity, administered through an intravenous route currently being investigated in a Phase 1 clinical trial.

 

Dive into our Colorectal Cancer Pipeline Report to uncover promising therapies and breakthroughs. Gain insights that could shape the future of oncology @ Colorectal Cancer Treatment Therapies

  

Colorectal Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

 

Colorectal Cancer Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy

 

Dive into our detailed Colorectal Cancer Pipeline Report to discover groundbreaking advancements shaping the future of cancer treatment @ Colorectal Cancer Products, Companies, and Unmet Needs

 

Scope of the Colorectal Cancer Pipeline Report

  • Coverage- Global
  • Colorectal Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Colorectal Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
  • Colorectal Cancer Companies- Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences, Inc., Neogap Therapeutics AB, Criterium, Inc., Daiichi Sankyo, Inc., Bristol-Myers Squibb, Celyad Oncology SA, Pfizer, Akeso, Menarini Group, Elpiscience (Suzhou) Biopharma, Ltd., BeyondBio Inc., Shanghai Henlius Biotech, Rottapharm Biotech, Innovative Cellular Therapeutics Inc., BioNTech SE, and others.
  • Colorectal Cancer Therapies- Patritumab Deruxtecan, Adagrasib, Geptanolimab, PolyPEPI1018, Grapiprant, eFT508, MEN1611, Aldoxorubicin Hydrochloride, Etrumadenant, AL2846, ABI-009, RO7198457, Dabrafenib, AlloStim, TG6002, Onvansertib, BLYG8824A, Napabucasin, GM102, QL1203, CPGJ602, PM060184, Donafenib, IBI310, Spartalizumab, CMAB009, YYB101, ATP128, Vicriviroc, CXD101, Arfolitixorin, SGM-101, RRx-001, APR003, E7386, Trastuzumab, Trilaciclib, MGN1703, BBI608, CYAD-101, SHR-A1811,  EDP1503, SCT-I10A, KL-140, V941, NKTR-255, TEW-7197, MGD019, KPT-8602, GRT-C901, LUM015, IDE196, CAN04, NC410, LOAd703, CEA CAR-T cells, BOLD-100, OBI-833, GRT-C903, IGM-8444, RGX-202-01, NE-201, DS-8201, GCC19CART, M 9140, LYL845, and others.

 

Gain valuable insights into emerging therapies and innovations with our Colorectal Cancer Pipeline Report @ Colorectal Cancer Market Drivers and Barriers, Future Perspectives and Analyst Views

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Colorectal Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Comparative Analysis
  8. XL092: Exelixis
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Early Stage Products (Phase I)
  12. LYL845: Lyell Immunopharma
  13. Inactive Products
  14. Colorectal Cancer Key Companies
  15. Colorectal Cancer Key Products
  16. Colorectal Cancer – Unmet Needs
  17. Colorectal Cancer – Market Drivers and Barriers
  18. Colorectal Cancer – Future Perspectives and Conclusion
  19. Colorectal Cancer Analyst Views
  20. Colorectal Cancer Key Companies
  21. Appendix

  

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Colorectal Cancer Pipeline Drugs 2024 | Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences Inc.

Meat Products Market Overview, Growth Opportunities, Drivers, Key Segments, Industry News, Regional Analysis, and Leading Players

“MarketsandMarkets™”
Meat Products Market by Animal (Beef, Pork, Poultry), Type (Processed, Frozen, Canned/Preserved, Chilled, Fresh), Distribution Channel (Retail, Food Service, E-Commerce), Nature, Packaging, and Region – Global Forecast to 2028

The meat products market size is valued at USD 44.3 billion in 2023 and is expected to grow to USD 68.9 billion by 2028, with a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2023 to 2028. The global market for meat products is an ever-changing and varied segment within the food industry, comprising items such as beef, poultry, pork, lamb, and processed meats. In recent years, there has been a consistent rise in the demand for meat products, propelled by various factors, and this trend shows no signs of slowing down.

Meat Products Market

A key factor fuelling this increased demand is the continual growth of the world’s population, especially in emerging markets. As populations expand and disposable incomes increase, there is a corresponding rise in the consumption of meat as a primary source of protein. Urbanization is another significant driver, reshaping dietary preferences as more individuals move to cities, leading to a preference for processed and convenient meat products that cater to busy lifestyles.

Meat Products Market Drivers: Rising Demand for Meat-based Convenience Foods

The shift towards urbanization, characterized by the growing migration of people from rural to urban areas, has had a significant influence on the meat products market. One of the key factors driving this market growth is the convenience of processed and pre-packaged meat items. Urban lifestyles, often fast-paced and with limited time for traditional cooking, make these products particularly appealing due to their pre-cut, marinated, and easy-to-cook nature. Additionally, the compact living spaces and busy, on-the-go routines common in urban environments enhance the appeal of these products, which require minimal kitchen equipment and cater to the need for quick and portable meals. The rich culinary diversity in cities, reflecting various cultures and cuisines, further boosts the demand for processed meats that suit a wide range of tastes. Furthermore, the assurance of food safety and quality is crucial for urban consumers, who may have limited access to fresh, locally sourced meats. In conclusion, the convenience provided by processed and pre-packaged meat products is a major driver of market growth in urban areas, effectively meeting the varied needs and preferences of city dwellers.

Meat Products Market Opportunities: Technological Advancement in Meat Processing Industry

Technological advancements are revolutionizing the meat industry, driving its growth and transformation. These innovations are enhancing product quality, extending shelf life, and reducing waste. Modern meat processing equipment enables precise, controlled methods, ensuring consistent cuts that meet high standards for taste and quality. This demonstrates the industry’s commitment to safety and regulatory compliance while also boosting consumer satisfaction.

In packaging, technologies like Modified Atmosphere Packaging and vacuum sealing create controlled environments that extend the shelf life of meat products, addressing food waste concerns and promoting sustainability. Advanced processing equipment also supports waste reduction by maximizing meat utilization and minimizing trimmings and byproducts that would otherwise be discarded. Additionally, innovations in packaging materials contribute to eco-friendly practices by reducing excessive packaging.

The integration of technology into the meat industry significantly enhances operational efficiency. Automation and robotics are increasingly prevalent in meat processing facilities, streamlining operations, boosting productivity, and lowering labor costs. Automated systems for cutting, trimming, and portioning not only improve efficiency but also ensure product consistency and reduce the risk of human error. Moreover, technological advancements enable traceability and quality control through data, barcoding, and RFID systems, allowing real-time monitoring and tracking of products throughout the supply chain, thereby strengthening safety measures and regulatory compliance.

Sustainability is a key focus in the meat industry’s adoption of technological innovations. By emphasizing waste reduction, quality improvement, and the use of energy-efficient equipment, the industry is working to minimize its environmental footprint. Ultimately, the meat industry’s embrace of new technologies positions it to meet evolving consumer demands, reduce environmental impact, and maintain a competitive edge in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53140407

Frozen Meat Products: The Driving Force Behind Market Momentum in 2022

The rising popularity of frozen meat in the meat products market highlights shifting consumer preferences and lifestyle needs. As busy schedules become more common, convenience and efficiency are top priorities for consumers. Frozen meat products, offering a range of processed options, provide a quick and easy meal solution with minimal preparation. The flash-freezing process not only enhances convenience but also extends product shelf life while maintaining nutritional value, aligning with the growing focus on food safety and quality. The global demand for diverse culinary experiences further fuels the need for a wider variety of meats, which frozen options readily satisfy. Innovations in freezing technologies, such as Individual Quick Freezing (IQF) and cryogenic freezing, have significantly improved the quality of frozen meat products. This growing preference is transforming the meat products market, driving expansion, increasing competition, and broadening global reach. Manufacturers and retailers are responding with creative strategies and targeted marketing, creating a dynamic and competitive industry landscape. As the frozen meat segment gains momentum, it presents promising opportunities for both consumers and industry stakeholders, shaping the future direction of the meat market.

Europe is the Fastest-Growing Market for Meat Products Among the Regions.

The European market presents substantial business opportunities for meat product manufacturers, largely driven by the region’s increasing focus on health awareness. This growing health consciousness has spurred a rise in demand for meat products, with a growing number of manufacturers entering the market and launching new products. Key factors influencing this trend include concerns about sustainability and a stronger emphasis on health practices.

The trend towards adopting new dietary preferences and health-conscious decisions is fueling the growth of the meat products market in Europe. The region is home to numerous major players in the meat industry, who are actively exploring ways to strengthen their market presence. These manufacturers are employing strategies such as product launches, expanding production capacities, and forming partnerships and acquisitions with other industry players to broaden their geographical reach and assert dominance in the European meat products market. For instance, in August 2022, the Netherlands-based Vion Group made significant investments to expand its operations in eastern Germany, particularly in Thuringia and Brandenburg. The company is committed to promoting regionalism in food retail by focusing on providing fresh beef and pork products that meet the growing demand for local and regional options, including organic choices. This approach aims to reduce carbon footprints and improve animal welfare by minimizing transport times.

Top Meat Products Companies:

The key players in this market include Cargill, Incorporated (US), JBS SA (Brazil), Tyson Foods, Inc. (Arkansans), Hormel Foods Corporation (US), Vion Group (Netherlands).

Tyson foods, Inc.

Tyson Foods, Inc. (NYSE: TSN) is a global food corporation renowned as a leading figure in the protein industry worldwide. Established in 1935, the company, now under its fourth generation of family leadership, has solidified its position as a major player in the food sector. Headquartered in Springdale, Arkansas, Tyson Foods boasts a workforce of approximately 142,000 employees. With a diverse array of products and brands catering to different markets, including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidella, IBP, and State Fair, the company is committed to innovation. This commitment is evident in their continuous efforts to enhance the sustainability of protein production, tailor products to meet global market demands, and set higher standards for the positive impact of quality food.

Tyson Foods operates across four primary segments: Beef, Pork, Chicken, and Prepared Foods. The International/Other category encompasses international operations and additional activities. In the Beef segment, the company processes live fed cattle into primal and sub-primal meat cuts, supplying a diverse range of products to both domestic and international markets. The Pork segment focuses on processing live market hogs, transforming pork carcasses into various products, while the Chicken segment involves the raising and processing of live chickens, offering fresh, frozen, and value-added chicken products. With a significant global footprint, Tyson Foods has a presence in approximately 140 countries and regions. The company conducts operations and holds interests in various countries, including China, the Netherlands, Australia, Mexico, Malaysia, and more.

Hormel Foods Corporation

Hormel Foods Corporation, a Delaware-based entity established in 1891, has grown into a prominent figure in the global food industry, with its headquarters in Austin, Minnesota. The company’s primary focus lies in the processing, manufacturing, and distribution of branded, value-added consumer food products, underpinned by a commitment to quality, innovation, and integrity.

As a leading player in the global food market, Hormel Foods has a significant presence in over 80 countries and boasts an impressive annual revenue surpassing USD 12 billion. Its journey of growth and diversification has been shaped by a blend of organic expansion and strategic acquisitions. Internationally, Hormel Foods Corporation utilizes its wholly owned subsidiary, Hormel Foods International Corporation (HFIC), to market products in major global markets such as Australia, Brazil, Canada, China, England, Japan, Mexico, Micronesia, the Philippines, Singapore, and South Korea.

Meat Products Industry News

1. In September 2023, Minerva Foods SA (Brazil) has completed its acquisition of Breeders and Packers Uruguay SA (BPU Meat), a subsidiary of NH Foods, with a total investment of USD 40 million. With this acquisition, Minerva Foods significantly enhanced its total slaughter capacity, which now reaches 3,700 heads per day, distributed across four refrigeration units, including the newly acquired BPU Meat.

2. In August 2023, Minerva Foods SA (Brazil) has acquired the majority of Marfrig’s cattle and sheep slaughtering and deboning operations in South America. The deal cost USD 1.45 billion. The transaction is expected to deepen Minerva’s geographical diversification

3. In July 2023, Vion Zucht- und Nutzvieh (Netherlands) and Danish Crown have entered a contract for cattle slaughtering services in Schleswig-Holstein. Commencing from August 1, 2023, Danish Crown will undertake the slaughter of up to 1,000 young bulls, cows, and heifers per week on behalf of Vion Food Group. This helps them to produce a large quantity of meat to meet the demand of consumers.

4. In May 2023, The Danish Crown (Denmark) acquired the SELO Verpakking and SELO Belgium, (Benlux). With the acquisition of the majority stake in the SELO companies gives them a perfect platform to grow their business in Benelux.

5. In March 2023, Hormel Foods (US), the maker of HORMEL BLACK LABEL Bacon, has introduced a unique product called “Hardcourt Smoked HORMEL BLACK LABEL Bacon.” This bacon is smoked using actual northern cherry maple wood that is used to make the basketball courts for the 2023 college basketball tournament.

Book a meeting with our experts to discuss your business needs @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=53140407

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/meat-products-market-53140407.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Meat Products Market Overview, Growth Opportunities, Drivers, Key Segments, Industry News, Regional Analysis, and Leading Players